May 21, 2026
8 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Two bills were recently proposed in the U.S. Senate to cap out-of-pocket insulin spending at $35 per month for Americans with commercial health insurance. Sens. Jeanne Shaheen, D-N.H., Susan Collins, R-Maine, John Kennedy, R-La., and Raphael Warnock, D-Ga., introduced the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act on March 25. The legislation includes four
May 21, 2026
8 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

The INSULIN Act would cap insulin costs for privately insured patients as Congress considers broader measures targeting drug…

Bills in Congress could directly lead to lower patient out-of-pocket costs for items like insulin and may indirectly impact…

State legislation that caps out-of-pocket insulin costs for people with diabetes does not cover most Americans with the disease,…

The search for affordability wins is leading U.S. senators back to capping the cost of insulin at $35 in the private insurance…

A three-year effort to reduce the cost of insulin for Medicare beneficiaries has achieved its primary goals, lowering…

The Senate health committee advanced 13 healthcare bills to the Senate floor, including hospital prices and food regulations.